The effect of different hypertension models on visual evoked potentials

International Journal of Neuroscience

Volumn 112, Issue 11, 2002, Pages 1321-1335

  Hacioglu, Gulay ^a   Agar, Aysel ^a   Ozkaya, Gul ^a   Yargicoglu, Piraye ^a   Gumuslu, Saadet ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

DOCA; Hypertension; Lipid peroxidation; Plasma renin activity; Visual evoked potential

Indexed keywords

NITRITE; RENIN;

ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; EVOKED VISUAL RESPONSE; FLUOROMETRY; HIPPOCAMPUS; HYPERTENSION; KIDNEY; LIPID PEROXIDATION; MALE; METABOLISM; METHODOLOGY; PHYSIOLOGY; RAT; RETINA; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, VISUAL; FLUOROMETRY; HIPPOCAMPUS; HYPERTENSION; KIDNEY; LIPID PEROXIDATION; MALE; NITRITES; RATS; RATS, WISTAR; RENIN; RETINA; VASOCONSTRICTION;

EID: 0036859935     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450290158223     Document Type: Article

References (31)

1. Amiri, F., & Garcia, R. (1997). Renal angiotensin II receptor regulation in two-kidney, one-clip hypertensive rats. Effect of ACE inhibition. Hypertension, 30, 337-344.
2. Bachmann, S., Bosse, H. M., & Mundel, P. (1995). Topography of nitric oxide synthesis by localizing constitutive NO syntheses in mammalian kidney. American Journal of Physiology, 268, F885-F898.
3. Brown, M. J. (1997). Science, medicine, and the future. Hypertension, BMJ, 314, 1258-1261.
4. Crillo, D., Gonfiantini, E., Degrandis, D., Bongiovanni, L., Robert, J. J., & Pinelli, L. (1984). Visual evoked potentials in diabetic children and adolescents. Diabetes Care, 7, 273-275.
5. DeArtinano, A. A., & Gonzalez, V. L. M. (1999). Endothelial dysfunction and hypertensive vasoconstriction. Pharmacological Research, 40, 113-124.
6. A receptor in the maintenance of deoxycor-ticosterone acetate-salt-induced hypertension. British Journal of Pharmacology, 114, 925-930.
7. Hedge, L. G., Srivastavo, P., Kumari, R., & Dikshit, M. (1998). Alterations in the vasoreactivity of hypertensive rat aortic rings: Role of nitric oxide and superoxide radicals. Clinical and Experimental Hypertension, 20, 885-901.
8. Hertzler, B. E., Boyes, W. C., Creason, J., & Dyer, R. S. (1988). Temperature dependent changes in visual evoked potentials of rats. Electroencephalography and Clinical Neurophysiology, 70, 137-154.
9. Houston, M. C. (1989). New insights and new approaches for the treatment of essential hypertension: Selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life and subsets of hypertension. American Heart Journal, 117, 911.
10. Hutri-Kahönen, N., Porsti, I., Wu, X., Tolvanen, J. P., Sallinen, K., & Kahönen, M. (1997). Arterial responses to bradykinin after ramipril therapy in experimental hypertension. Pharmacology & Toxicology, 81, 190-196.
11. Lariviere, R., St-Louis, J., & Schiffrin, E. L. (1988). Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats. Journal of Hypertension, 6, 211-217.
12. Lowry, O. H., Rosenbrough, N. J., Far, A. L., & Randel, R. J. (1951). Proteinmeasurement with folin-phenol reagent. Journal of Biological Chemistry, 193, 265-275.
13. Munzel, T., Heitzer, T., & Harrison, D. G. (1997). The physiology and pathophysiology of the nitric oxide/superoxide system. Herz, 22, 158-172.
14. Ohta, T., Arai, Y., & Takitani, S. (1986). Fluorometric determination of nitrite with 4-hydroxycoumarin. Analytical Chemistry, 58, 3132-3135.
15. Ohta, Y., Yamasaki, T., Niwa, T., Niimi, K., Majima, Y., & Ishiguro, I. (1996). Role of catalase in retinal antioxidant defense system: Its comparative study among rabbits, guinea pigs and rats. Ophthalmic Research, 28, 236-242.
16. Oyekan, A. O., Mcward, K., Conetta, J., Rosenfeld, L., & McGiff, C. F. (1999). Endothelin-I and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension. American Journal of Physiology, 276, R766-R775.
17. Roman, G. C. (1987). Senile dementia of Binswanger type: A vascular form of dementia in the elderly. Journal of American Medical Association, 258, 1782-1788.
18. Sakuma, I., Shudo, H., Togashi, H., Yoshioka, M., Saito, H., Nakamura, T., Fujioka, Y., Kitabatake, A., & Levi, R. (1994). A chronic model of hypertension with increased sympathetic drive in the rat by inhibition of nitric oxide synthase. Biology of Nitric Oxide-3 Physiological and Clinical Aspects (pp. 245-247). Portland, OR: Portland Press.
19. Satia, M. C., Damani, R. R., & Goyal, R. K. (1997). Beneficial effects of clonidine in streptozotocin-induced diabetes and DOCA-hypertensive rats. Journal of Pharmacy and Pharmacology, 49, 1030-1035.
20. Scheinberg, P. (1988). Dementia due to vascular disease a multifactorial disorder. Stroke 19, 1291-1299.
21. Schnackenberg, C. G., Tabor, B. L., Strong, M. H., & Granger, J. P. (1997). Inhibition of intrarenal NO stimulates renin secretion through a macula dense-mediated mechanism. American Journal of Physiology, 272, R879-R886.
22. Scholz, H., & Kurtz, A. (1994). Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney. Journal of Clinical Investigation, 91, 1088-1094.
23. Schriffin, E. L., Gutkowska, J., & Genest, J. (1981). Mechanism of captopril induced renin release in conscious rats. Proceedings of the Society for Experimental Biology and Medicine, 167, 327-332.
24. Swales, J. D. (1984). Etiology of hypertension. British Journal of Anesthesia, 56, 677.
25. Tandon, O. P., & Ram, D. (1997). Visual evoked potentials in primary hypertension. Indian Journal of Physiology and Pharmacology, 41, 154-158.
26. Tostes, R. C. A., Wilde, D. W., Bendhack, L. M., & Webb, R. C. (1997). Calcium handling by vascular myocytes in hypertension. Brazilian Journal of Medical and Biological Research, 30, 315-323.
27. Ujiie, K., Yuen, J., Hogarth, L., Danziger, R., & Star, R. A. (1994). Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. American Journal of Physiology, 267, F296-F302.
28. Volpe, M., Sosa, E., Muller, F. B., Camargo, M. J. F., Glorioso, N., Laragh, J. H., Maack, T., & Atlas, S. A. (1986). Differing hemodynamic responses to atrial natriuretic factor in two models of hypertension. American Journal of Physiology, 250, H871-H878.
29. Wasowicz, W., Jean, N., & Peratz, A. (1993). Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum. Importance of extraction pH and influence of sample, preservation and storage. Clinical Chemistry, 39, 2522-2526.
30. Wilson, S. K., Lynch, D. R., & Ladenson, P. W. (1989). Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: Comparative receptor localization and changes in different hypertension models in the rat. Endocrinology, 124, 2799-2808.
31. Yu, H., Rakugi, H., Higaki, J., Morishita, R., Mikami, H., & Ogihara, T. (1993). The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one-clip hypertensive rats. Journal of Hypertension, 11, 1347-1355.